Neurological injury in primary Sjogren's syndrome.

PSS central nervous system involvement neurological injury primary Sjogren’s syndrome

Journal

Annals of medicine and surgery (2012)
ISSN: 2049-0801
Titre abrégé: Ann Med Surg (Lond)
Pays: England
ID NLM: 101616869

Informations de publication

Date de publication:
Jul 2023
Historique:
received: 11 04 2023
accepted: 29 05 2023
medline: 10 7 2023
pubmed: 10 7 2023
entrez: 10 7 2023
Statut: epublish

Résumé

The incidence of neurological injury in primary Sjogren's syndrome varies between 2.5 and 60%. The authors aimed to evaluate its prevalence and characteristics in patients with primary Sjogren's syndrome in a sample of the Syrian population. Forty-eight patients with primary Sjogren's syndrome, attending outpatient clinics at Damascus Hospital between January 2020 and January 2022 in this cross-sectional study at the outpatient clinics, were interviewed and examined, and the necessary laboratory and radiological examinations were demanded. Information was collected on disease duration, onset time, and patterns of neurological symptoms. Forty-eight patients, including 42 females, aged 56.1±10.3 years were enroled.Central nervous system involvement was found in 34 patients. 85% of patients had generalized nerve manifestations, while local nerve manifestations were found in 77,5% of patients. The common neurological manifestation was headaches, then cognitive disorders, and the most common pattern of headache was migraine. Beck Depression Index showed a significant increase in the apathy evaluation scale.The study of cognitive changes showed a significant increase in the Mini-Mental State Examination (MMSE) index.Carotid Doppler showed the presence of injury in 42.4% of patients. The magnetic resonance imaging showed positive findings in 21 patients and positive evoked potentials in 52% of patients. Studies showing the prevalence of Sjogren's neurological injury patterns are insufficient, but this was changed when the criteria for diagnosing Sjogren's syndrome was modified, and the definition of neurological traits in the context of the syndrome was expanded.The presence of a high rate of headaches, cognitive changes, and fatigue confirms that generalized nervous system injuries are more common than local injuries. Migraine was the most common pattern of headache found in patients with the syndrome compared with other patterns such as tension headaches and headaches due to medications, especially analgesics.This was associated with the presence of anti-SSA antibodies and Raynaud's phenomenon, which suggest that the headache mechanism may be due to vascular endothelial dysfunction or an immune-mediated inflammation injury of the neurovascular system.The changes that appeared on the MRI images suggested premotor cortex involvement rather than mesolimbic cortical impairment, and its presence was also associated with SSA antibody positivity, and it is caused by inflammation. Primary Sjogren's syndrome should be considered as having any unspecified or specific neurological disorder.

Identifiants

pubmed: 37427219
doi: 10.1097/MS9.0000000000000937
pii: AMSU-D-23-00836
pmc: PMC10328669
doi:

Types de publication

Journal Article

Langues

eng

Pagination

3381-3385

Informations de copyright

Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc.

Déclaration de conflit d'intérêts

NA.

Références

J Clin Med. 2020 Jul 20;9(7):
pubmed: 32698400
BMC Psychiatry. 2021 Oct 4;21(1):485
pubmed: 34607584
J Stroke Cerebrovasc Dis. 2021 Feb;30(2):105517
pubmed: 33285353
Medicine (Baltimore). 2004 Sep;83(5):280-291
pubmed: 15342972
Ther Adv Musculoskelet Dis. 2018 Feb;10(2):39-54
pubmed: 29387177
Scand J Rheumatol. 2018 Mar;47(2):141-154
pubmed: 28927315
Curr Opin Neurol. 2010 Oct;23(5):509-13
pubmed: 20689426
Ann Med Surg (Lond). 2022 Jul 31;80:104243
pubmed: 36045773
Autoimmune Dis. 2012;2012:645967
pubmed: 22474573
Ann Med Interne (Paris). 1995;146(4):239-42
pubmed: 7653943
Int J Surg. 2019 Dec;72:156-165
pubmed: 31704426
Diagnostics (Basel). 2022 Dec 21;13(1):
pubmed: 36611306
Health Qual Life Outcomes. 2019 Aug 5;17(1):136
pubmed: 31382960
Cancer Treat Rev. 2021 Jun;97:102189
pubmed: 33872978
Brain Nerve. 2013 Nov;65(11):1333-42
pubmed: 24200611
J Neurol. 2001 Jul;248(7):577-84
pubmed: 11517999
Life (Basel). 2023 Mar 03;13(3):
pubmed: 36983849
Arthritis Rheum. 2002 Mar;46(3):748-54
pubmed: 11920411
Curr Treatm Opt Rheumatol. 2017 Dec;3(4):275-288
pubmed: 30627507
J Pharmacol Pharmacother. 2013 Dec;4(Suppl 1):S94-8
pubmed: 24347992
Arthritis Care Res (Hoboken). 2017 Apr;69(4):517-527
pubmed: 27390247
Dement Geriatr Cogn Disord. 2021;50(2):111-123
pubmed: 33975314
Rheumatology (Oxford). 2015 Mar;54(3):441-8
pubmed: 25193805
PLoS One. 2014 Jan 20;9(1):e84605
pubmed: 24465419
Front Immunol. 2019 Jul 11;10:1600
pubmed: 31354737
Reumatologia. 2018;56(2):99-105
pubmed: 29853725
J Clin Neurol. 2021 Apr;17(2):164-175
pubmed: 33835736
Ann Med Interne (Paris). 1999 Dec;150(8):598-604
pubmed: 10686641

Auteurs

Naram Khalayli (N)

Resident in Internal Medicine.

Mhd Fares Bouri (MF)

Syrian Private University, Daraa, Syria.

Molham Wahbeh (M)

Syrian Private University, Daraa, Syria.

Tasneem Drie (T)

Resident in Internal Medicine.

Maysoun Kudsi (M)

Professor in Rheumatology, Paculty of Medicine, Damascus University, Damascus.

Classifications MeSH